UBS Group’s Opko Health OPK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
– Sell
-500,000
Closed -$5.3M – 7958
2016
Q3
$5.3M Hold
500,000
– – ﹤0.01% 1969
2016
Q2
$4.67M Buy
500,000
+471,400
+1,648% +$4.79M ﹤0.01% 2000
2016
Q1
$297K Buy
28,600
+27,900
+3,986% +$255K ﹤0.01% 4187
2015
Q4
$7K Hold
700
– – ﹤0.01% 7522
2015
Q3
$6K Sell
700
-5,000
-88% -$66.2K ﹤0.01% 7609
2015
Q2
$92K Hold
5,700
– – ﹤0.01% 5467
2015
Q1
$81K Sell
5,700
-55,300
-91% -$720K ﹤0.01% 5601
2014
Q4
$609K Buy
+61,000
New +$522K ﹤0.01% 4017

Other funds holding OPK

UBS Group's OPK Position: Q3 2026 in Review

UBS Group reduced its Opko Health (OPK) stake by 42% in Q3 2026, selling an estimated $3.03M and leaving 2,917,608 shares worth $4.7M. The position accounts for ﹤0.01% of the portfolio, ranked #4174.

UBS Group first reported a position in OPK in Q4 2014 and has held it in 48 quarters since. The position peaked at $19.9M in Q3 2017. 224 funds tracked by Wall St. Rank hold OPK as of Q3 2026.

  • UBS Group held 2,917,608 shares of Opko Health worth $4.7M as of Q3 2026.
  • UBS Group sold 2,088,676 Opko Health shares in Q3 2026, an estimated $3.03M.
  • Opko Health made up ﹤0.01% of UBS Group's portfolio in Q3 2026, its #4174 holding.
  • UBS Group first reported a position in Opko Health in Q4 2014 and has held it in 48 quarters since.
  • UBS Group's Opko Health position peaked at $19.9M in Q3 2017.
  • 224 funds tracked by Wall St. Rank held Opko Health as of Q3 2026.

Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.